Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Pfizer Inc (NYSE: PFE) was $24.47 for the day, down -0.45% from the previous closing price of $24.58. In other words, the price has decreased by -$0.45 from its previous closing price. On the day, 36.26 million shares were traded. PFE stock price reached its highest trading level at $24.78 during the session, while it also had its lowest trading level at $24.39.
Ratios:
Our analysis of PFE’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.03 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.40. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 1.26. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 22, 2025, initiated with a Neutral rating and assigned the stock a target price of $24.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Underperform rating and target price of $25.Wolfe Research initiated its Underperform rating on November 15, 2024, with a $25 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 23 ’25 when Dolsten Mikael bought 59,781 shares for $23.09 per share.
Dolsten Mikael bought 55,000 shares of PFE for $1,312,736 on May 05 ’25. On Mar 04 ’25, another insider, DAMICO JENNIFER B., who serves as the SVP & Controller of the company, sold 2,500 shares for $25.93 each. As a result, the insider received 64,825 and left with 11,850 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PFE now has a Market Capitalization of 139121000448 and an Enterprise Value of 183190257664. As of this moment, Pfizer’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.73, and their Forward P/E ratio for the next fiscal year is 7.93. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.23 while its Price-to-Book (P/B) ratio in mrq is 1.54. Its current Enterprise Value per Revenue stands at 2.933 whereas that against EBITDA is 7.855.
Stock Price History:
The Beta on a monthly basis for PFE is 0.49, which has changed by -0.17331082 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, PFE has reached a high of $31.54, while it has fallen to a 52-week low of $20.92. The 50-Day Moving Average of the stock is 2.07%, while the 200-Day Moving Average is calculated to be -4.19%.
Shares Statistics:
PFE traded an average of 42.70M shares per day over the past three months and 40719060 shares per day over the past ten days. A total of 5.68B shares are outstanding, with a floating share count of 5.67B. Insiders hold about 0.18% of the company’s shares, while institutions hold 67.02% stake in the company. Shares short for PFE as of 1749772800 were 106732210 with a Short Ratio of 2.62, compared to 1747267200 on 107376473. Therefore, it implies a Short% of Shares Outstanding of 106732210 and a Short% of Float of 1.8800000000000001.
Dividends & Splits
With its trailing 12-month dividend rate of 1.69, PFE has a forward annual dividend rate of 1.70. Against a Trailing Annual Dividend Yield of 0.06875509The stock’s 5-year Average Dividend Yield is 4.58. The current Payout Ratio is 119.94% for PFE, which recently paid a dividend on 2025-05-09 with an ex-dividend date of 2025-07-25. Stock splits for the company last occurred on 2020-11-17 when the company split stock in a 1054:1000 ratio.
Earnings Estimates
The stock of Pfizer Inc (PFE) is currently drawing attention from 16.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $0.86, with high estimates of $0.98 and low estimates of $0.58.
Analysts are recommending an EPS of between $3.32 and $2.8 for the fiscal current year, implying an average EPS of $3.0. EPS for the following year is $3.09, with 23.0 analysts recommending between $3.47 and $2.73.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 15 analysts. It ranges from a high estimate of $13.66B to a low estimate of $13.1B. As of the current estimate, Pfizer Inc’s year-ago sales were $13.28BFor the next quarter, 15 analysts are estimating revenue of $17.11B. There is a high estimate of $17.82B for the next quarter, whereas the lowest estimate is $16.72B.
A total of 24 analysts have provided revenue estimates for PFE’s current fiscal year. The highest revenue estimate was $63.96B, while the lowest revenue estimate was $60.6B, resulting in an average revenue estimate of $62.44B. In the same quarter a year ago, actual revenue was $63.63BBased on 23 analysts’ estimates, the company’s revenue will be $62.26B in the next fiscal year. The high estimate is $64.38B and the low estimate is $59.17B.
